PGEN as reported
Precigen, Inc. reported $22M of revenue over the trailing twelve months. 11 reported series are charted on this page, each one as filed.
$22M
Revenue, trailing twelve months · to Q2 2023 · every figure below is as filed, with no scoring applied
- Net Income
- −$204M
Net Income · +30% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- −$117M
Free Cash Flow · +55% year on year · trailing twelve months to Q1 2026
- EPS
- −$1.18
EPS · +111% year on year · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $22M | n/a | Q2 2023 · 11 quarters behind |
| Net Income | −$204M | +30% | Q1 2026 |
| EPS | −$1.18 | +111% | Q1 2026 |
| Gross Margin | 81% | n/a | Q2 2018 · 31 quarters behind |
| Op Margin | −93% | n/a | Q4 2020 · 21 quarters behind |
| Net Margin | −778% | n/a | Q2 2023 · 11 quarters behind |
| ROE | −615% | n/a | Q1 2026 |
| ROA | −144% | n/a | Q1 2026 |
| ROIC | −65% | n/a | Q4 2020 · 21 quarters behind |
| Free Cash Flow | −$117M | +55% | Q1 2026 |
| P/E | 10.9 | n/a | Q2 2023 · 11 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Precigen, Inc. (PGEN) - Revenue & ProfitRevenue & ProfitPrecigen, Inc. (PGEN)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com